Clinical Trials
4 trialsNCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06709196 2025-01-09
REINFORCE
Rigshospitalet, Denmark
Phase 4 Recruiting
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT00035425 2009-12-01
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Pfizer
Phase 3 Completed